US › Healthcare

Azitra Inc (AZTR)

US · Healthcare · Biotechnology

$0.73+1.03%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.3M

EPS

$-0.17

EPS estimate

$-0.21

EPS came in at -0.17 against a street estimate of -0.21 — a beat of 19.0%.

Key statistics

Market cap

$4.4M

Forward P/E

0.0

P/B

0.73

Book value

$1.21

EPS (TTM)

$-2.80

52-week high

$4.30

52-week low

$0.52

50-day MA

$1.35

200-day MA

$1.80

Beta

-0.90

Analyst view

Analysts rate Azitra Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.50.

Shareholding

Insiders

7.59%

Institutions

32.04%

Corporate actions

Action	Detail	Date
Split	1 : 10 effective Oct 26, 2026	2026-10-26

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Azitra Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.